OxSonics Launches New Website & Renames as OxSonics Therapeutics

Oxford, UK – 7th January 2019 – OxSonics, a world leader in the development of ultrasound-based drug delivery systems for the treatment of cancer today announced the launch of its new website and its new name “OxSonics Therapeutics”. Colin Story, CEO, commented: “OxSonics Therapeutics innovative drug delivery platform is designed to deliver significant therapeutic advantages to those […]

OxSonics’ Cofounder Professor Coussios Presents at the Royal Society

Oxford, UK – 24th October 2018 – OxSonics cofounder and Chief Technology Officer Professor Constantin Coussios is an invited speaker at a scientific meeting of the Royal Society on the subject of “Delivering novel therapies in the 21st century”. Professor Coussios’ talk entitled “Shaken and Stirred: Ultrasound-enhanced Drug Delivery” will include data generated using OxSonics proprietary drug delivery platform […]